cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0002260,C0027819,TREATS,Eflornithine,Neuroblastoma,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0003250,C0024301,TREATS,Monoclonal Antibodies,"Lymphoma, Follicular",aapp,neop,1,TREATS_AAPPtrtsNEOP
C0003250,C0334634,TREATS,Monoclonal Antibodies,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",aapp,neop,1,TREATS_AAPPtrtsNEOP
C0003993,C0023449,TREATS,ASPARAGINASE,Acute lymphocytic leukemia,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0003993,C0079731,TREATS,ASPARAGINASE,B-Cell Lymphomas,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0004480,C0007097,TREATS,Azaserine,Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0010590,C0006826,TREATS,Cycloserine,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0010590,C0027627,TREATS,Cycloserine,Neoplasm Metastasis,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0010590,C0334634,TREATS,Cycloserine,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",aapp,neop,1,TREATS_AAPPtrtsNEOP
C0010590,C0677930,TREATS,Cycloserine,primary tumor,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0010934,C0006826,TREATS,Dactinomycin,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0021743,C1266119,TREATS,Interferon Type I,Solitary fibrous tumor,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0021745,C0027651,TREATS,Interferon Type II,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0021747,C0006118,TREATS,Interferons,Brain Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0021747,C0027651,TREATS,Interferons,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0021747,C1266119,TREATS,Interferons,Solitary fibrous tumor,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0021747,C2239176,TREATS,Interferons,Liver carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0023610,C0877373,TREATS,Gonadorelin,advanced cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0030946,C0006826,TREATS,Endopeptidases,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0034862,C0206708,TREATS,"Vaccines, Recombinant",Cervical Intraepithelial Neoplasia,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0037668,C0006826,TREATS,Somatotropin-Releasing Hormone,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0040005,C0007097,TREATS,Threonine,Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0041236,C0032580,TREATS,TRYPSIN,Adenomatous Polyposis Coli,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0041236,C0343079,TREATS,TRYPSIN,"Milia, Multiple Eruptive",aapp,neop,2,TREATS_AAPPtrtsNEOP
C0041368,C0027651,TREATS,Tumor Necrosis Factors,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0053355,C0278881,TREATS,ubenimex,stage II melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0085297,C1266119,TREATS,"Immunoglobulins, Intravenous",Solitary fibrous tumor,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0085741,C0027651,TREATS,"Pancreatic Trypsin Secretory Inhibitor, Kazal",Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0103306,C0006826,TREATS,angiotensin I (1-7),Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0114832,C0025202,TREATS,Dopachrome isomerase,melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0123759,C0017636,TREATS,Interleukin-12,Glioblastoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0123759,C0025202,TREATS,Interleukin-12,melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0123759,C0027651,TREATS,Interleukin-12,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0123759,C2239176,TREATS,Interleukin-12,Liver carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0169658,C0027651,TREATS,Janus kinase 1,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0206492,C0027651,TREATS,"Antibodies, Bispecific",Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0218986,C0278678,TREATS,Aldesleukin,Metastatic Renal Cell Cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0245109,C0007621,TREATS,anakinra,Neoplastic Cell Transformation,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0281549,C0006826,TREATS,Zenapax,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0296773,C0006826,TREATS,polysaccharide peptide,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0301521,C0006826,TREATS,therapeutic vaccine,Malignant Neoplasms,aapp,neop,4,TREATS_AAPPtrtsNEOP
C0301521,C0007114,TREATS,therapeutic vaccine,Malignant neoplasm of skin,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0301521,C0007847,TREATS,therapeutic vaccine,Malignant tumor of cervix,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0301521,C0027651,TREATS,therapeutic vaccine,Neoplasms,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0301521,C0877373,TREATS,therapeutic vaccine,advanced cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0301521,C0940937,TREATS,therapeutic vaccine,precancerous lesions,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0358321,C0027651,TREATS,Immune Globulin (Human),Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0376659,C0025202,TREATS,Cancer Vaccines,melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0376659,C0027651,TREATS,Cancer Vaccines,Neoplasms,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0376659,C0740457,TREATS,Cancer Vaccines,Malignant neoplasm of kidney,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0376659,C0877373,TREATS,Cancer Vaccines,advanced cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0393022,C0006826,TREATS,rituximab,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0393022,C0024314,TREATS,rituximab,Lymphoproliferative Disorders,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0393022,C0854866,TREATS,rituximab,Recurrent Non-Hodgkin Lymphoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0534191,C0376545,TREATS,recombinant FVIIa,Hematologic Neoplasms,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0534628,C0006118,TREATS,Endostatins,Brain Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0556082,C1391732,TREATS,Amino acid supplement,Cancer Wasting,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0717670,C0079773,TREATS,denileukin diftitox,"Lymphoma, T-Cell, Cutaneous",aapp,neop,1,TREATS_AAPPtrtsNEOP
C0728747,C0006142,TREATS,trastuzumab,Malignant neoplasm of breast,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0728747,C0278488,TREATS,trastuzumab,Carcinoma breast stage IV,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0770558,C0238462,TREATS,Human calcitonin,Medullary carcinoma of thyroid,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0796392,C0006826,TREATS,bevacizumab,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0796392,C0027651,TREATS,bevacizumab,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0796392,C0877373,TREATS,bevacizumab,advanced cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0879427,C0948380,TREATS,panitumumab,metastatic colorectal cancer,aapp,neop,2,TREATS_AAPPtrtsNEOP
C0879624,C0007131,TREATS,TG4010,Non-Small Cell Lung Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0912332,C0007102,TREATS,Glucagon-Like Peptide 2,Malignant tumor of colon,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0912332,C0334044,TREATS,Glucagon-Like Peptide 2,Dysplasia,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0995188,C0009402,TREATS,cetuximab,Colorectal Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C0995188,C0280100,TREATS,cetuximab,Solid Neoplasm,aapp,neop,1,TREATS_AAPPtrtsNEOP
C1367202,C0025202,TREATS,ipilimumab,melanoma,aapp,neop,3,TREATS_AAPPtrtsNEOP
C1367202,C0278883,TREATS,ipilimumab,Metastatic melanoma,aapp,neop,6,TREATS_AAPPtrtsNEOP
C1522712,C1266119,TREATS,Recombinant Interferon-alpha Inducible Protein 10,Solitary fibrous tumor,aapp,neop,6,TREATS_AAPPtrtsNEOP
C1527233,C0006826,TREATS,Recombinant Immune Globulin,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C1743549,C0948380,TREATS,Vectibix,metastatic colorectal cancer,aapp,neop,1,TREATS_AAPPtrtsNEOP
C1831854,C0029925,TREATS,catumaxomab,Ovarian Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C1831854,C0220656,TREATS,catumaxomab,Malignant ascites,aapp,neop,3,TREATS_AAPPtrtsNEOP
C1831854,C0280100,TREATS,catumaxomab,Solid Neoplasm,aapp,neop,1,TREATS_AAPPtrtsNEOP
C2001856,C0026764,TREATS,carfilzomib,Multiple Myeloma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C2346820,C0006826,TREATS,MDX-1106,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3154308,C0278883,TREATS,Yervoy,Metastatic melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3537035,C0220630,TREATS,kinase inhibitor,Adult Liver Carcinoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3537035,C1306058,TREATS,kinase inhibitor,Primary malignant neoplasm of kidney,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3537035,C4329281,TREATS,kinase inhibitor,Advanced Malignant Solid Neoplasm,aapp,neop,3,TREATS_AAPPtrtsNEOP
C3657270,C0007131,TREATS,nivolumab,Non-Small Cell Lung Carcinoma,aapp,neop,2,TREATS_AAPPtrtsNEOP
C3657270,C0025202,TREATS,nivolumab,melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3657270,C0242379,TREATS,nivolumab,Malignant neoplasm of lung,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3657270,C0278883,TREATS,nivolumab,Metastatic melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3657270,C0346429,TREATS,nivolumab,Multiple malignancy,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3665678,C0006826,TREATS,CT-011,Malignant Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3853839,C0006413,TREATS,blinatumomab,Burkitt Lymphoma,aapp,neop,2,TREATS_AAPPtrtsNEOP
C3853839,C0023449,TREATS,blinatumomab,Acute lymphocytic leukemia,aapp,neop,3,TREATS_AAPPtrtsNEOP
C3853839,C0220656,TREATS,blinatumomab,Malignant ascites,aapp,neop,1,TREATS_AAPPtrtsNEOP
C3872108,C0025202,TREATS,Opdivo,melanoma,aapp,neop,1,TREATS_AAPPtrtsNEOP
C4055105,C0027651,TREATS,EGFR Antibody,Neoplasms,aapp,neop,1,TREATS_AAPPtrtsNEOP
